4133 — Abnova Taiwan Share Price
0.000.00%
Last trade - 00:00- TWD1.89bn
- TWD1.47bn
- TWD382.05m
- 66
- 29
- 30
- 33
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.47 | ||
| Price to Tang. Book | 1.55 | ||
| Price to Free Cashflow | 33.29 | ||
| Price to Sales | 4.94 | ||
| EV to EBITDA | 18.5 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 3.65% | ||
| Return on Equity | 3.39% | ||
| Operating Margin | 12.35% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | TWDm | 414.16 | 456.45 | 451.49 | 411.76 | 382.05 | n/a | n/a | -2.16% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -92.91 | +1021.34 | -20.58 | +157.66 | -37.45 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
ABNOVA (TAIWAN) CORPORATION is a Taiwan-based company principally engaged in the manufacturing and sales of antibodies and proteins. The Company's products mainly include monoclonal antibodies, polyclonal antibodies, protein fragments, full-length proteins, active proteins, antibody pairs, fluorescence in situ hybridization probe and others. The Company's monoclonal and polyclonal antibodies are primarily applied in medical testing reagents, agricultural testing, industrial purification, medical treatment and other fields. Its proteins are mainly applied in medical testing reagents, agricultural testing, medical treatment, protein engineering and other fields. Its products are mainly traded in Taiwan, Americas and Europe.
Directors
- Wilber Huang CHM
- Hanwen Guan DGM
- Yaping Zhang OTH
- Yuehong Chen DRC
- Fangwen Li DRC
- Qijing Qiu DRC
- Jiaxun Lin IND
- Jinjun Su IND
- Shaode Ye IND
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- January 4th, 2002
- Public Since
- May 27th, 2008
- No. of Employees
- 190
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Taiwan Stock Exchange
- Shares in Issue
- 60,554,000
- Address
- 9F, No.108, Jhouzih Street, TAIPEI, 114
- Web
- https://www.abnova.com/
- Phone
- +886 287511888
- Contact
- Peiru Ji
- Auditors
- KPMG LLP
Upcoming Events for 4133
Abnova Taiwan Corp Annual Shareholders Meeting
Similar to 4133
Applied BioCode
Taiwan Stock Exchange
Energenesis Biomedical Co
Taiwan Stock Exchange
Kim Forest Enterprise Co
Taiwan Stock Exchange
PHARMAESSENTIA
Taiwan Stock Exchange
Pell Bio Med Technology Co
Taiwan Stock Exchange
FAQ
What is the Abnova Taiwan share price?
As of Today at 19:00 UTC, shares in Abnova Taiwan are trading at TWD31.15. This share price information is delayed by 15 minutes.
How has the Abnova Taiwan share price performed this year?
Shares in Abnova Taiwan last closed at TWD31.15 and the price had moved by -11.63% over the past 365 days. In terms of relative price strength the Abnova Taiwan share price has underperformed the FTSE Developed Asia Pacific Index by -11.55% over the past year.
What are the analyst and broker recommendations for Abnova Taiwan?
There is no consensus recommendation for this security.
What is the Abnova Taiwan dividend yield?
The Abnova Taiwan dividend yield is 2.31% based on the trailing twelve month period.
Does Abnova Taiwan pay a dividend?
Last year, Abnova Taiwan paid a total dividend of TWD0.72, and it currently has a trailing dividend yield of 2.31%. We do not have any data on when Abnova Taiwan is to next pay dividends.
When does Abnova Taiwan next pay dividends?
We do not have data on when Abnova Taiwan is to next pay dividends. The historic dividend yield on Abnova Taiwan shares is currently 2.31%.
How do I buy Abnova Taiwan shares?
To buy shares in Abnova Taiwan you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Abnova Taiwan?
As of the previous close price of TWD31.15, shares in Abnova Taiwan had a market capitalisation of TWD1.89bn.
Where are Abnova Taiwan shares listed?
Here are the trading details for Abnova Taiwan:
- Country of listing: Taiwan
- Exchange: TAI
- Ticker Symbol: 4133
What kind of share is Abnova Taiwan?
Based on an overall assessment of its quality, value and momentum Abnova Taiwan is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Abnova Taiwan share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Abnova Taiwan share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Abnova Taiwan. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -13.13%.
As of the last closing price of TWD31.15, shares in Abnova Taiwan were trading -5.58% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Abnova Taiwan PE Ratio?
The Abnova Taiwan PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at TWD31.15.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Abnova Taiwan?
Abnova Taiwan's management team is headed by:
- Wilber Huang - CHM
- Hanwen Guan - DGM
- Yaping Zhang - OTH
- Yuehong Chen - DRC
- Fangwen Li - DRC
- Qijing Qiu - DRC
- Jiaxun Lin - IND
- Jinjun Su - IND
- Shaode Ye - IND